health
-
Aeroband Hits the Right Note at SXSW: The Best Smart Musical Instrument Brand Inspiring the Future of MusicDetails
Unleash the Rhythm of Inspiration at SXSW with Aeroband AUSTIN,Texas,March 10,2025-- Aeroband,a leader in smart music technology,announces its participation at the 2025 South by Southwest (SXSW) Festi
-
Indonesian Students Achieve Success at The Hong Kong Polytechnic UniversityDetails
Join Our Event at the Pullman Jakarta Central Park on 23 March 2025 HONG KONG,March 10,2025-- Choosing the right university is a pivotal decision for many students,given the numerous options and the c
-
TCI Biotech Announces Strong 2024 Financial Performance, Sets Sights on Global Growth in 2025Details
TAIPEI,March 10,2025-- TCI Biotech (TCI Co.,Ltd.) (TWSE: 8436),a leading CDMO+ innovator in health food and skincare biotechnology,has released its consolidated financial results for the fiscal year e
-
Johnson Controls-Hitachi Air Conditioning Powering Indonesia's Hotel TransformationDetails
JAKARTA,Indonesia,March 11,2025-- As Indonesia\'s hospitality sector recovers and grows in the energy transition era,Johnson Controls-Hitachi Air Conditioning Indonesia,a global leader in HVAC technol
-
Global Times: Up Close: President Xi takes part in deliberation of Jiangsu delegationDetails
BEIJING,March 8,2025-- Chinese PresidentXi Jinping,also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission,took part in a deliberation
-
NUS-spinoff technology AutoCodeRover acquired by Sonar, accelerating AI-driven software developmentDetails
SINGAPORE,March 10,2025-- AutoCodeRover,an autonomous AI agent platform for software development which is a spin-off technology of the National University of Singapore (NUS),has been acquired by Sona
-
Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLCDetails
CHENGDU,China,March 10,2025--SichuanKelun-BiotechBiopharmaceuticalCo.,Ltd. (the"Company") announced that the Company\'s trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conj
-
ChipMOS REPORTS FEBRUARY 2025 REVENUEDetails
HSINCHU,March 10,2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider o
-
World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer DetectionDetails
Prospective study findsLunit AI increases cancer detection by 13.8% in single-reader settings without raising recall rates,presenting a game-changing tool for countries relying on single-reader mammo
-
STRADVISION Surpasses 3 Million Units in Cumulative Production, Achieving a Record-Breaking Year in 2024Details
SEOUL,South Korea,March 11,2025--STRADVISION,a global leader in AI-powered vision perception technology,proudly announces a new industry milestone,surpassing 3 million units in cumulative commercial